All babies to be tested for rare condition.
Those babies who have their newborn bloodspot sample from this month will be offered screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD).
Babies with MCADD, a rare inherited condition, have problems breaking down fats to make energy for their body. This can lead to serious illness, or even death.
Newborn bloodspot screening means that babies who have MCADD can be identified early and parents can receive specialist advice. This allows special attention to be given to the baby's diet, including making sure they feed regularly.
Dr Sharon Hillier, deputy director of the screening division of Public Health Wales, said: "The introduction of MCADD screening puts Wales in line with other UK countries where this test is already available."
Newborn bloodspot screening is carried out by a midwife in the first five to eight days of a baby's life. Drops of blood are collected from the baby's heel.
The screening division has also launched a new information leaflet explaining newborn bloodspot screening, which will be given to all parents of newborn babies in Wales, and a new website for Newborn Bloodspot Screening Wales. For more information visit www.newbornbloodspotscreening.wales.nhs.uk
|Printer friendly Cite/link Email Feedback|
|Publication:||South Wales Echo (Cardiff, Wales)|
|Date:||Jun 8, 2012|
|Previous Article:||Carnival lives on after Big Weekend shelved.|
|Next Article:||Blaszczykowski is living the dream; Poland v Greece Group A: Warsaw, 5pm.|